Heron Therapeutics (HRTX) Misses Q1 EPS by 2c
Heron Therapeutics (NASDAQ: HRTX) reported Q1 EPS of ($0.70), $0.02 worse than the analyst estimate of ($0.68).
For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.
Heron Therapeutics (NASDAQ: HRTX) reported Q1 EPS of ($0.70), $0.02 worse than the analyst estimate of ($0.68).
For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.